Senior QA Specialist

Lonza

Visp, Switzerland

In Visp, we are looking for a QA specialist to join multifunctional QA Operations team in the Bioconjugates Business unit who will support to establish and maintain quality management & compliance processes. You will work closely with various quality, engineering and operational functions to ensure cGMP compliant manufacturing and documentation.

What you’ll do:

  • Coordinate QA interests during different project phases.
  • Responsible for project specific QA Operation tasks during Commissioning/Qualification.
  • Responsible for review and final release of records such as Standard Operating Procedures (SOPs), Master Manufacturing.
  • Batch Records, Material Specifications, Quality Risk Assessments, Deviations, CAPAs, Change Requests, Effectiveness Checks, Testing Protocols & Reports…etc.
  • Managing independently stakeholders and their needs in a customer focused environment.
  • Participate and support regulatory inspections and customer audits.

What we’re looking for:

  • Bachelor’s or master’s degree in biotechnology, Biochemistry, or a related field.
  • Significant experience in biopharmaceutical manufacturing, preferably in a QA function.
  • Strong background in cGMP and broad knowledge in biotechnological manufacturing processes, validation approaches and risk management.
  • Sound experience in representing Quality and Compliance in projects.
  • Good communication skills and experience in interaction with all kind of interfaces within the organization.
  • Experience in the use of the following systems would be preferred: TrackWise, LIMS, DMS and SAP.
  • Excellent written and spoken English - knowledge of written and spoken German would be an advantage.

Don't forget to mention EuroPharmaJobs when applying.

Share this Job

More Job Searches

Switzerland      Biotechnology and Genetics      Manufacturing and Logistics      On-site      Pre-clinical Research and Development      Quality Assurance      Lonza     

EuroPharmaJobs Logo

© EuroJobsites 2025